Navigation Links
Free Prostate Screenings Offered at Virginia G. Piper Cancer Center
Date:9/2/2010

SCOTTSDALE, Ariz., Sept. 2 /PRNewswire-USNewswire/ -- Recognizing that early detection can save lives, the Virginia G. Piper Cancer Center at Scottsdale Healthcare is offering free prostate cancer screenings from 8:30 a.m.-12 p.m. on Saturday, Sept. 11.

Urologists from Scottsdale Healthcare will be available to answer questions and talk about prostate cancer diagnosis and treatment options. Free prostate screenings include a Prostate Specific Antigen blood test and digital rectal exam.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare is located at 10460 N. 92nd St. on the campus of Scottsdale Healthcare Shea Medical Center.

Appointments for the screening can be made by calling 480-882-4636.

  • Hear about prostate cancer diagnosis and treatment options at 8:30 a.m. and 10:45 a.m.
  • See nutrition and cooking demonstrations for prostate health at 9:30 a.m. and 10:30 a.m.
  • Adult flu shots will be available for $25.
  • Get 25% off at Tina's Treasures Boutique, dedicated to meeting the needs of cancer patients.

Attendees can take the controls of a daVinci robotic surgical system to experience the precision it offers in minimally invasive surgery. Arizona's first daVinci robot-assisted prostatectomy was performed by surgeons at Scottsdale Healthcare.

The daVinci is the world's leading surgical robot for minimally invasive procedures, which result in smaller incisions, less post-operative pain and faster recovery times. Scottsdale Healthcare has the longest experience with the daVinci robot of any Arizona hospital, acquiring the state's first daVinci in 2001.

Surgeons are now using three of the high-tech daVinci robots at Scottsdale Healthcare Thompson Peak Hospital and Scottsdale Healthcare Shea Medical Center. One of Scottsdale Healthcare's experienced daVinci surgeons will be on hand to answer questions about robotic surgery.

According to the American Cancer Society:

  • 1 in 6 men is at a lifetime risk of prostate cancer.
  • About 1 man in 36 will die of prostate cancer.
  • Almost 2 out of 3 prostate cancers are found in men over age 65.
  • Prostate cancer is the second leading cause of cancer death in American men.
  • Other than skin cancer, prostate cancer is the most common cancer in American men.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare opened in 2001 as the first major cancer center in greater Phoenix, offering comprehensive cancer research, diagnosis, treatment, prevention and support services in a single location. The Commission on Cancer of the American College of Surgeons has awarded Accreditation with Commendation to the Scottsdale Healthcare cancer program.

Scottsdale Healthcare is the community-based, not-for-profit parent organization of the Scottsdale Healthcare Osborn Medical Center, Scottsdale Healthcare Shea Medical Center and Scottsdale Healthcare Thompson Peak Hospital, Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale Healthcare Research Institute and Scottsdale Healthcare Foundation. A leader in medical innovation, talent and technology, Scottsdale Healthcare was founded in 1962 and is based in Scottsdale, Ariz. For more information, visit www.shc.org.


'/>"/>
SOURCE Scottsdale Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
3. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
6. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
11. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/13/2017)... ATLANTA , Sept. 13, 2017   OrthoAtlanta ... to the Atlanta Football Host Committee (AFHC) for the 2018 ... Monday, Jan. 8, 2018, at Mercedes-Benz Stadium in ... part of the AFHC "I,m In" campaign, participating in many ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):